Systematic Review: Inhaled corticosteroids for the treatment of COVID‐19.

Inhaled corticosteroids for the treatment of COVID‐19 – Cochrane Library

Related:

[Preprint] M-A: Inhaled corticosteroids in COVID-19 outpatients.

PRINCIPLE RCT: Inhaled budesonide improves time to recovery from COVID-19 in people at high risk of complications in the community.

Position Paper: Recommendations for the use of topical inhalant budesonide in COVID-19.

RCT: Inhaled budesonide shortens recovery time in non-hospitalized patients with COVID-19

Phase 2 RCT: Inhaled budesonide shows promise for the treatment of early COVID-19

Commentary on Twitter (thread – click for more)

https://twitter.com/CochraneLibrary/status/1501615982208507912